Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Single Center Study Evaluating The Clinical Performance and Safety of Hyaluronic Acid-Based Implantable Dermal Fillers Applied to the Face
Authors not listed
Semikal Technology · 2024
Abstract
The aim of the study is to verify safety and performance of Semical dermal fillers according to real-world data.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Anonymous. (2024). A Single Center Study Evaluating The Clinical Performance and Safety of Hyaluronic Acid-Based Implantable Dermal Fillers Applied to the Face. <em>Semikal Technology</em>. https://clinicaltrials.gov/study/NCT07160777
Vancouver
Anonymous. A Single Center Study Evaluating The Clinical Performance and Safety of Hyaluronic Acid-Based Implantable Dermal Fillers Applied to the Face. Semikal Technology. 2024.
BibTeX
@misc{anon2024ASingl,
title = {A Single Center Study Evaluating The Clinical Performance and Safety of Hyaluronic Acid-Based Implantable Dermal Fillers Applied to the Face},
author = {Anonymous},
journal = {Semikal Technology},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2021
Open access · US-GOV
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules
Diabetologia 2011
Open access · OA
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study
Eisai Inc. 2012
Open access · US-GOV
A Randomized, Open-label, 3-treatment Crossover Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption in Healthy Caucasian Male Adults
Galaxia Empírica 2023
Open access · US-GOV
Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 2021
Open access · US-GOV
An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Efficacy of LX102-C01 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 2014
Open access · US-GOV